alexa Abstract | Effects Of Emblica Officinalis Commercial Formulation In Type 2 Diabetic Patients

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Paper Open Access


The levels of blood glucose and malondialdehyde in type 2 diabetic patients have been studied after the administration of amalakic capsules containing 250 mg fruit powder of Emblica officinalis twice a day for 60 d. It was observed that the drug treatment decreases blood glucose levels from 203±82 mg/dl (initial) to 189±255.2 mg/dl (after 60 d of treatment). However, the decrease was statistically insignificant (p>0.05). On the other hand, administration of amalaki for the same period of time resulted in a significant decrease in malondialdehyde levels from 7.55±2.3 nM (initial) to 5.36±0.8 nM (after 60 d of treatment). The decrease in the levels of the malondialdehyde was statistically significant (p<0.05). In the present study, no direct relationship was observed between blood glucose levels and malondialdehyde levels (lipid peroxide levels) of type 2 diabetic patients.

To read the full article Peer-reviewed Article PDF image

Author(s): R H Chandra C Veeresham K Asres

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version